Oxford Immunotec Global (Oxford Immunotec Global) EV-to-EBIT : -22.87 (As of Apr. 26, 2024)

Oxford Immunotec Global EV-to-EBIT Chart

Oxford Immunotec Global Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19
EV-to-EBIT		Get a 7-Day Free Trial				-7.47	-12.52	-10.25	-8.23	-53.07

Oxford Immunotec Global Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
EV-to-EBIT	Get a 7-Day Free Trial															-	-	-	-	-7.92

Competitive Comparison of Oxford Immunotec Global's EV-to-EBIT

For the Diagnostics & Research subindustry, Oxford Immunotec Global's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Immunotec Global's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford Immunotec Global's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Oxford Immunotec Global's EV-to-EBIT falls into.

Oxford Immunotec Global EV-to-EBIT Calculation

Oxford Immunotec Global's EV-to-EBIT for today is calculated as:

Oxford Immunotec Global's current Enterprise Value is $410.51 Mil.
Oxford Immunotec Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford Immunotec Global  (NAS:OXFD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Oxford Immunotec Global's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:

Oxford Immunotec Global's Enterprise Value for the quarter that ended in Sep. 2020 was $151.81 Mil.
Oxford Immunotec Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford Immunotec Global EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Oxford Immunotec Global's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Immunotec Global (Oxford Immunotec Global) Business Description